Skip to main content
SpringerLink
Log in

Supportive Care in Paediatric Oncology

  • Chapter
  • First Online:
The MASCC Textbook of Cancer Supportive Care and Survivorship

  • 1224 Accesses

Abstract

Although childhood cancer represents about 1% of all cancer cases, it comprises worldwide around 250,000 children yearly. Globally, this gives an age-standardised incidence rate of 140 per million per year [1] (http://www-dep.iarc.fr/accis.htm).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kellie SJ, Howard SC. Global child health priorities: what role for paediatric oncologists? Eur J Cancer 2008;44(16):2388–96.

    Article  PubMed  Google Scholar 

  2. Ribeiro RC, Steliarova-Foucher E, Magrath I, Lemerle J, Eden T, Forget C, et al. Baseline status of paediatric oncology care in ten low-income or mid-income countries receiving My Child Matters support: a descriptive study. Lancet Oncol 2008;9(8):721–9.

    Article  PubMed  Google Scholar 

  3. Wyke JA. Science, the UICC and global cancer control. Int J Cancer 2004;110(4):471–4.

    Article  PubMed  CAS  Google Scholar 

  4. Bleyer WA, Tejeda H, Murphy SB, Robison LL, Ross JA, Pollock BH, et al. National cancer clinical trials: children have equal access; adolescents do not. J Adolesc Health 1997;21(6):366–73.

    Article  PubMed  CAS  Google Scholar 

  5. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis 2007;45(10):1296–304.

    Article  PubMed  Google Scholar 

  6. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34(6):730–51.

    Article  PubMed  Google Scholar 

  7. Ritchey A. The pediatric oncology group, supportive care manual. 1-9-1996. Smthkline Beecham.

    Google Scholar 

  8. Cardous-Ubbink MC, Heinen RC, Langeveld NE, Bakker PJ, Voute PA, Caron HN, et al. Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer 2004;42(7):563–73.

    Article  PubMed  CAS  Google Scholar 

  9. Gardner A, Mattiuzzi G, Faderl S, Borthakur G, Garcia-Manero G, Pierce S, et al. Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. J Clin Oncol 2008;26(35):5684–8.

    Article  PubMed  Google Scholar 

  10. Hawkins J. Supportive care: managing febrile neutropenia. Paediatr Nurs 2009;21(4):33–7.

    PubMed  Google Scholar 

  11. Gafter-Gvili A, Fraser A, Paul M, van de WM, Kremer L, Leibovici L. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev 2005;(4):CD004386.

    Google Scholar 

  12. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005;142(12 Pt 1):979–95.

    PubMed  Google Scholar 

  13. van de Wetering MD, de Witte MA, Kremer LC, Offringa M, Scholten RJ, Caron HN. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. Eur J Cancer 2005;41(10):1372–82.

    Article  PubMed  Google Scholar 

  14. Hovi L, Saxen H, Saarinen-Pihkala UM, Vettenranta K, Meri T, Richardson M. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders. Pediatr Blood Cancer 2007;48(1):28–34.

    Article  PubMed  Google Scholar 

  15. Bow EJ, Laverdiere M, Lussier N, Rotstein C, Cheang MS, Ioannou S. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials. Cancer 2002;94(12):3230–46.

    Article  PubMed  CAS  Google Scholar 

  16. Prentice AG, Glasmacher A, Djulbegovic B. In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy. Br J Haematol 2006;132(5):656–8.

    Article  PubMed  CAS  Google Scholar 

  17. Simon A, Besuden M, Vezmar S, Hasan C, Lampe D, Kreutzberg S, et al. Itraconazole prophylaxis in pediatric cancer patients receiving conventional chemotherapy or autologous stem cell transplants. Support Care Cancer 2007;15(2):213–20.

    Article  PubMed  Google Scholar 

  18. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356(4):348–59.

    Article  PubMed  CAS  Google Scholar 

  19. Sathiapalan RK, El Solh H. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature. Pediatr Hematol Oncol 2001;18(8):543–6.

    Article  PubMed  CAS  Google Scholar 

  20. Sathiapalan RK, Al Nasser A, El Solh H, Al Mohsen I, Al Jumaah S. Vincristine-itraconazole interaction: cause for increasing concern. J Pediatr Hematol Oncol 2002;24(7):591.

    Article  PubMed  Google Scholar 

  21. Thomas CF, Jr., Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350(24):2487–98.

    Article  PubMed  CAS  Google Scholar 

  22. Shankar SM, Nania JJ. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy. Paediatr Drugs 2007;9(5):301–9.

    Article  PubMed  Google Scholar 

  23. Kim SY, Dabb AA, Glenn DJ, Snyder KM, Chuk MK, Loeb DM. Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients. Pediatr Blood Cancer 2008;50(4):779–83.

    Article  PubMed  Google Scholar 

  24. Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 1996;14(6):1957–60.

    Google Scholar 

  25. Sung L, Nathan PC, Lange B, Beyene J, Buchanan GR. Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22(16):3350–6.

    Article  PubMed  CAS  Google Scholar 

  26. Pizzo PA. Fever in immunocompromised patients [see comments]. N Engl J Med 1999;341(12):893–900.

    Article  PubMed  CAS  Google Scholar 

  27. Roguin A, Kasis I, Ben Arush MW, Sharon R, Berant M. Fever and neutropenia in children with malignant disease. Pediatr Hematol Oncol 1996;13(6):503–10.

    Article  PubMed  CAS  Google Scholar 

  28. Mendes AV, Sapolnik R, Mendonca N. New guidelines for the clinical management of febrile neutropenia and sepsis in pediatric oncology patients. J Pediatr (Rio J) 2007;83(2 Suppl):S54–S63.

    Article  Google Scholar 

  29. NCCN practice guidelines for fever and neutropenia. National Comprehensive Cancer Network. Oncology (Huntingt) 1999;13(5A):197–257.

    Google Scholar 

  30. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children ­compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99(3):580–8.

    Article  PubMed  CAS  Google Scholar 

  31. Sung L, Johnston DL. Approach to febrile neutropenia in the general paediatric setting. Paediatr Child Health 2007;12(1):19–21.

    PubMed  Google Scholar 

  32. Paulus S, Dobson S. Febrile neutropenia in children with cancer. Adv Exp Med Biol 2009;634:185–204.

    Article  PubMed  Google Scholar 

  33. Arendrup MC, Fisher BT, Zaoutis TE. Invasive fungal infections in the paediatric and neonatal population: diagnostics and management issues. Clin Microbiol Infect 2009;15(7):613–24.

    Article  PubMed  CAS  Google Scholar 

  34. te Poele EM, Tissing WJ, Kamps WA, de Bont ES. Risk assessment in fever and neutropenia in children with cancer: what did we learn? Crit Rev Oncol Hematol 2009;72(1):45–55.

    Article  PubMed  Google Scholar 

  35. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 2009;31(9):623–9.

    Article  PubMed  Google Scholar 

  36. Mermel LA, Farr BM, Sherertz RJ, Raad II, O’Grady N, Harris JS, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001;32(9):1249–72.

    Article  PubMed  CAS  Google Scholar 

  37. Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009;374(9684):159–69.

    Article  PubMed  Google Scholar 

  38. Patel SR, Chisholm JC, Heath PT. Vaccinations in children treated with standard-dose cancer therapy or hematopoietic stem cell transplantation. Pediatr Clin North Am 2008;55(1):169–86, xi.

    Article  PubMed  Google Scholar 

  39. Goossen GM, Kremer LC, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev 2009;(2):CD006484.

    Google Scholar 

  40. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007;120(1):221–31.

    Article  Google Scholar 

  41. Tosi P, Barosi G, Lazzaro C, Liso V, Marchetti M, Morra E, et al. Consensus conference on the management of tumor lysis syndrome. Haematologica 2008;93(12):1877–85.

    Article  PubMed  Google Scholar 

  42. Navolanic PM, Pui CH, Larson RA, Bishop MR, Pearce TE, Cairo MS, et al. Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. Leukemia 2003;17(3):499–514.

    Article  PubMed  CAS  Google Scholar 

  43. Zernikow B, Schiessl C, Wamsler C, Janssen G, Griessinger N, Fengler R, et al. [Practical pain control in pediatric oncology. Recommendations of the German Society of Pediatric Oncology and Hematology, the German Association for the Study of Pain, the German Society of Palliative Care, and the Vodafone Institute of Children’s Pain Therapy and Palliative Care]. Schmerz 2006;20(1):24–39.

    Article  PubMed  CAS  Google Scholar 

  44. Wong DL, Baker CM. Pain in children: comparison of assessment scales. Pediatr Nurs 1988;14(1):9–17.

    PubMed  CAS  Google Scholar 

  45. Rheingans JI. A systematic review of nonpharmacologic adjunctive therapies for symptom management in children with cancer. J Pediatr Oncol Nurs 2007;24(2):81–94.

    Article  PubMed  Google Scholar 

  46. van de Wetering M. Supportive care during treatment. P.A. Voute, A. Barrett, M. Stevens, H. Caron, editors. Cancer in Children; Clinical Management. 5th, 86–93. 1-10-2005. Oxford, Oxford University Press.

    Google Scholar 

  47. American Academy of Pediatrics Committee on Drugs: Guidelines for monitoring and management of pediatric patients during and after sedation for diagnostic and therapeutic procedures. Pediatrics 1992;89(6 Pt 1):1110–5.

    Google Scholar 

  48. Practice guidelines for sedation and analgesia by non-anesthesiologists. A report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology 1996;84(2):459–71.

    Google Scholar 

  49. Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 2006;24(18):2932–47.

    Article  PubMed  CAS  Google Scholar 

  50. Herrstedt J. Antiemetics: an update and the MASCC guidelines applied in clinical practice. Nat Clin Pract Oncol 2008;5(1):32–43.

    Article  PubMed  CAS  Google Scholar 

  51. Dupuis LL, Taddio A, Kerr EN, Kelly A, MacKeigan L. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents. Pharmacotherapy 2006;26(9):1221–31.

    Article  PubMed  Google Scholar 

  52. Holdsworth MT, Raisch DW, Frost J. Acute and delayed nausea and emesis control in pediatric oncology patients. Cancer 2006;106(4):931–40.

    Article  PubMed  Google Scholar 

  53. Cardous-Ubbink MC, Heinen RC, Bakker PJ, van Den BH, Oldenburger F, Caron HN, et al. Risk of second malignancies in long-term survivors of childhood cancer. Eur J Cancer 2007;43(2):351–62.

    Article  PubMed  CAS  Google Scholar 

  54. Geenen MM, Cardous-Ubbink MC, Kremer LC, van Den BC, van der Pal HJ, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007;297(24):2705–15.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Oncology, Emma Children’s Hospital/Academic Medical Center, Meibergdreef 9, Amsterdam, 1105 AZ, The Netherlands

    Marianne D. van de Wetering

Authors
  1. Marianne D. van de Wetering
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wim J. E. Tissing
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marianne D. van de Wetering .

Editor information

Editors and Affiliations

  1. Clinical Professor, Cancer Coucil Australia, University of Sydney Medical School, Surry Hills, 2010, New South Wales, Australia

    Ian N. Olver

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Society for Imaging Informatics in Medicine

About this chapter

Cite this chapter

van de Wetering, M.D., Tissing, W.J.E. (2010). Supportive Care in Paediatric Oncology. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1225-1_6

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1224-4

  • Online ISBN: 978-1-4419-1225-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation